Cara Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RATHBONES GROUP PLC | 02/13/2025 | 20.16 K | $7.16 K | 0.00% | 0.04% |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 8.83 K | $2.74 K | -6.61% | 0.02% |
| JPMORGAN CHASE & CO | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| US BANCORP \DE\ | 02/05/2025 | 0 | $0 | -100.00% | 0.00% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| STIFEL FINANCIAL CORP | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| PINNACLE ASSOCIATES LTD | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| FERGUSON WELLMAN CAPITAL MANAGEMENT, INC | 01/29/2025 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| COMERICA BANK | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BALDWIN BROTHERS LLC/MA | 01/22/2025 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| FEDERATED HERMES, INC. | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| JAG CAPITAL MANAGEMENT, LLC | 02/06/2025 | 0 | $0 | -100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| AQR CAPITAL MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| LPL FINANCIAL LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| B. RILEY WEALTH ADVISORS, INC. | 02/25/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 01/30/2025 | 0 | $0 | -100.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 02/05/2025 | 0 | $0 | -100.00% | 0.00% |
| PENSERRA CAPITAL MANAGEMENT LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| CYPRESS CAPITAL MANAGEMENT LLC (WY) | 01/23/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cara Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 52 institutional investors and hedge funds held shares of Cara Therapeutics, Inc.. The most heavily invested institutionals were:
WR Wealth Planners, LLC: 0
FinTrust Capital Advisors, LLC: 260
BlackRock Inc.: 744,707
Point72 Middle East FZE: 0
ROTHSCHILD INVESTMENT CORP /IL: 10,600
Ergoteles LLC: 0
0.05% of Cara Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.69 M shares in the last 24 months. This purchase volume represents approximately $188.77 M in transactions.